The page is the record's research on the issuer — no analyst, no rating, no view. # ABVC BIOPHARMA, INC. (NASDAQ: ABVC) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is ABVC BIOPHARMA, INC., listed on NASDAQ under ticker ABVC, with ISIN US00091F3047. The LEI is not on the record, because no GLEIF record with the exact legal name in jurisdiction US-NV exists. The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Nevada. The segment is not on the record. The issuer is listed and not halted. ## The disclosure read The record holds 29 filings across 18 filing days in the window 2025-11-08 to 2026-11-08. The filings comprise 8 prospectus, 5 agm_egm, 5 regulatory_filing, 5 results, 4 corporate_news, 1 ad_hoc and 1 director_change. The median gap between filing days is 18 days. The latest filing is dated 2026-11-02 and is of type corporate_news, 6 days before the record date. The NASDAQ median cadence gap is 6.0 days, with a median of 52 filings and a median latency of 5.0 days across 4,359 issuers. The 2834 Pharmaceutical Preparations sector median cadence gap is 6.0 days, with a median of 63.0 filings and a median latency of 4.0 days across 526 issuers. ## Auditor The auditor of record is Simon & Edward, LLP, located in Rowland Heights, California. The record shows one auditor change, dated 2026-07-02. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The issuer is listed and not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001173313.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/ABVC (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1173313/000121390026023063/ea0278313-10k_abvcbio.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/ABVC (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/ABVC · public-record only · the same page signed and receipted: get_research at https://mcp.getissuer.ai/mcp